ATELLICA IM PROCALCITONINA (PCT) - COFEPRIS Registration 1300R2019 SSA
Access comprehensive regulatory information for ATELLICA IM PROCALCITONINA (PCT) (ATELLICA IM PROCALCITONINA (PCT)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1300R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on July 15, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA IM BRAHMS PROCALCITONIN (PCT) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE PROCALCITONINA (PCT) EN EL SUERO Y EL PLASMA HUMANOS (EDTA, HEPARINA DE LITIO Y HEPARINA DE SODIO), ASÍ COMO LOS CONTROLES PER
THE ATELLICA IM BRAHMS PROCALCITONIN (PCT) ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF PROCALCITONIN (PCT) IN HUMAN SERUM AND PLASMA (EDTA, LITHIUM HEPARIN AND SODIUM HEPARIN), AS WELL AS CONTROLS PER